Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials

E. CHO (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), N. Kang (Seoul, Republic of Korea), Y. Im (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), S. Lim (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea)

Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. CHO (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), N. Kang (Seoul, Republic of Korea), Y. Im (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), S. Lim (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea). Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials. 2004

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: